According to FutureWise analysis the market for Surgical Imaging Arms in 2023 is US$ 1.32 billion, and is expected to reach US$ 2.36 billion by 2031 at a CAGR of 7.50%.
Increasing globalization results in several disease outbreaks out of which some of them require surgical procedures. As per the Annual Plastic Surgery report by the American Society of Plastic Surgeons (ASPS), over 15 million minimally-invasive and surgical cosmetic operations were performed in the United States in 2015. This rising number of surgical procedures is stimulating the insistence for advanced surgical arms, thus contributing to the overall surgical imaging arms market growth.
Numerous manufacturers across the world are focussing on the manufacturing and development of advanced equipment which can aid the surgeons in carrying the surgical procedures smoothly and effectively. The rising insistence for mini C-arms devices can be attributed to features, for instance, easy adjustability in the operation theatre, lower price as compared to other types of C-arms and small size. Major players are emphasizing on developing high efficacy C-arm devices. For example, Hologic Inc. announced the
Fluoroscan Insight FD Mini C-arm in 2018. This system provides a flexible transport facility and imaging features that are improved due to low rate modes of dosages. These important developments shall possibly inflate the surgical imaging arms market size in the upcoming years. Although, expensive surgical imaging arms and technical errors present in these devices can possibly impede the market growth over the forecast period.
Currently, the trauma and orthopaedic surgery segment subjugate the market and it is estimated to continue its dominance over the forecast period due to a rise in the implementation of intraoperative surgical imaging while performing orthopedic surgery, surgical imaging systems being widely available for orthopedic surgery and soaring adoption of c-arm while performing orthopaedic implantation.